The relationship between thymidylate synthase polymorphisms and the efficacy of pemetrexed-based chemotherapy in patients with non-small cell lung cancer

YU Fei; LIU Xiaoqing; LI Xiaoyan; GUO Wanfeng; SUN Xuedong; ZHANG Yunmei

doi:10.3969/j.issn.1009-0460.2013.05.008

Home>Articles>The relationship between thymidylate synthase polymorphisms and the efficacy of pemetrexed-based chemotherapy in patients with non-small cell lung cancer

DOI: 10.3969/j.issn.1009-0460.2013.05.008

The relationship between thymidylate synthase polymorphisms and the efficacy of pemetrexed-based chemotherapy in patients with non-small cell lung cancer

YU Fei

LIU Xiaoqing

LI Xiaoyan

GUO Wanfeng

SUN Xuedong

ZHANG Yunmei

Machine-generated Keywords：

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 416-420 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(5)